Chinese robot maker Unitree has priced its Shanghai initial public offering at 150.80 yuan per share, seeking to raise 6.1 billion yuan ($904 million) in a deal that would make it the first mainland-listed humanoid robot manufacturer.

The IPO has attracted intense investor interest, with Unitree saying its retail tranche was more than 8,000 times oversubscribed. The listing values the company at 219 times its 2025 earnings and 36 times sales, highlighting the enormous expectations surrounding China’s rapidly developing humanoid robotics industry.

What Is Unitree?

Founded in 2016 by engineer Wang Xingxing, Hangzhou-based Unitree initially gained recognition for producing relatively inexpensive quadruped robots, commonly known as robot dogs.

The company later expanded into humanoid robotics with products including the G1, H1 and R1. Viral demonstrations of the robots running, dancing and performing martial arts have helped Unitree gain international attention.

Unitree is competing with companies such as Tesla and Boston Dynamics, alongside a growing number of Chinese startups seeking to develop robots capable of eventually performing tasks in factories and homes.

The company’s revenue increased more than fourfold to nearly 1.7 billion yuan ($252 million) in 2025. Unlike many humanoid robotics startups, Unitree is already profitable, reporting adjusted net profit of around 600 million yuan.

International markets are also important to the company, with overseas revenue accounting for more than 40% of sales during each reporting period disclosed in its prospectus.

However, Unitree has warned that geopolitical tensions and potential U.S. restrictions on trade, procurement or sales could affect its international expansion.

Who Is Backing Unitree?

Unitree has attracted investment from some of China’s biggest technology, telecommunications and automotive companies.

Meituan is the company’s largest outside investor, holding 9.65% through several affiliates. Startup investors HSG and MPCi hold 7.11% and 5.45%, respectively.

Tencent, Alibaba Group, Ant Group, China Mobile and Geely also invested through affiliated entities during a June 2025 funding round.

The company also has links to state-backed investors. The Beijing Robotics Industry Development Fund holds 3.83%, while the China Internet Investment Fund holds 2.11%.

Founder Wang Xingxing remains Unitree’s controlling shareholder.

Why Is Unitree Important?

Unitree has demonstrated China’s ability to manufacture sophisticated robots using relatively low-cost components, benefiting from the country’s extensive supply chains for motors, sensors, batteries and other technologies.

The company has also become an important symbol of China’s ambition to dominate embodied intelligence, a field that combines artificial intelligence with machines capable of interacting with the physical world.

But Unitree’s commercial success does not necessarily mean humanoid robots are ready to replace human workers on a large scale.

Current demand is still concentrated largely among universities and government-backed projects for education, research and demonstrations.

Humanoid robots continue to face difficulties with reliability, dexterity and the ability to perform different tasks for extended periods without human intervention.

Unitree itself acknowledges that widespread commercial adoption remains uncertain, citing challenges including task generalisation, endurance, safety and reliable operation in unstructured environments.

Why Are Chinese Robot Makers Seeking IPOs?

Humanoid robotics requires enormous investment.

Companies need to spend heavily on engineers, AI models, training data and manufacturing capacity, often years before large-scale demand from factories and households becomes certain.

Public markets therefore offer robotics companies a way to raise the capital required to continue developing their technology while government support and investor enthusiasm remain strong.

Unitree plans to use its IPO proceeds to develop embodied-AI models, advance robot-body research and expand manufacturing capacity.

Other Chinese companies are also moving toward public markets. Leju Robotics, which produces the Kuavo humanoid, filed an application in May to list on Shenzhen’s ChiNext market, while Shanghai-based AgiBot began preparations for a Hong Kong IPO in July.

Analysis: Why the IPO Race Matters

Unitree’s listing represents more than a major fundraising exercise. It reflects China’s broader effort to turn humanoid robotics into a commercially viable strategic industry.

The extraordinary demand for Unitree’s IPO shows how strongly investors believe the sector could grow. But the company’s valuation also demonstrates the gap between market expectations and the current maturity of humanoid robotics.

The industry still faces fundamental questions over whether humanoids can operate reliably, safely and economically outside controlled environments. Until those challenges are overcome, much of the industry’s future value remains based on expectations rather than proven mass-market demand.

For Chinese robotics companies, however, moving quickly to public markets provides an important advantage: access to large pools of capital while government policy, industrial supply chains and investor enthusiasm are aligned behind the sector.

The race to list therefore reflects a broader strategic competition over who will control the next generation of physical AI. Unitree’s IPO could become an important test of whether China’s advantage in manufacturing and supply chains can translate into global leadership in humanoid robotics.

With information from Reuters.